TrialThe Lancet. Child & adolescent health2023

Neuropsychiatric manifestations and sleep disturbances with dolutegravir-based antiretroviral therapy versus standard of care in children and adolescents: a secondary analysis of the ODYSSEY trial.

Anna Turkova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.